Proteomic Analysis of Human Endometrial Tissues Reveals the Roles of PI3K/AKT/mTOR Pathway and Tumor Angiogenesis Molecules in the Pathogenesis of Endometrial Cancer

被引:18
|
作者
Liu, Zhen [1 ,2 ,3 ]
Hong, Zhipan [4 ]
Qu, Pengpeng [3 ]
机构
[1] Tianjin Med Univ, Dept Obstet & Gynecol, Tianjin 300070, Peoples R China
[2] Inner Mongolia Med Univ, Chifeng Clin Med Sch, Chifeng Municipal Hosp, Dept Gynecol, Chifeng 024000, Peoples R China
[3] Tianjin Cent Hosp Gynecol & Obstet, Dept Gynecol Oncol, Tianjin 300070, Peoples R China
[4] Inner Mongolia Med Univ, Chifeng Municipal Hosp, Dept Tumor Surg, Chifeng Clin Med Sch, Chifeng 024000, Peoples R China
关键词
ENDOTHELIAL GROWTH-FACTOR; EXPRESSION; OSTEOPONTIN; ENVIRONMENT; PROTEINS; CATENIN; PI3K;
D O I
10.1155/2020/5273969
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
As one major gynecological malignancy, endometrial cancer (EC) has been widely studied recently. However, its pathogenesis is still unclear to date. In this study, we identified differentially expressed proteins between 30 endometrial cancer tissues and 30 matched normal controls using 2D LC-MS/MS quantitative proteomics. As a result, we identified 619 differentially expressed proteins among all 2521 proteins being quantified. Further analyses suggested that the changes of fat, amino acid metabolism, peroxisome, extracellular signal, cytoskeleton, and other signaling or metabolic pathways may be closely related to the development of this cancer. Particularly, the PI3K/AKT/mTOR pathway-related molecules including PI3K and mTOR, ERK (the molecule of the ERK pathway), SPP1, and ANGPT2 (angiogenesis-related molecules) are highly associated with the pathogenesis of EC, which were reconfirmed by western blot and immunohistochemistry (IHC) analysis. In summary, our study revealed that the PI3K/AKT/mTOR pathway and tumor angiogenesis molecules contribute to the pathogenesis of endometrial cancer.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Activation of PI3K/Akt/mTOR Pathway and Dual Inhibitors of PI3K and mTOR in Endometrial Cancer
    Chen, Jiezhong
    Zhao, Kong-Nan
    Li, Rui
    Shao, Renfu
    Chen, Chen
    CURRENT MEDICINAL CHEMISTRY, 2014, 21 (26) : 3070 - 3080
  • [2] The PI3K/AKT/mTOR Pathway as a Therapeutic Target in Endometrial Cancer
    Slomovitz, Brian M.
    Coleman, Robert L.
    CLINICAL CANCER RESEARCH, 2012, 18 (21) : 5856 - 5864
  • [3] 'Investigation of miRNAs That Affect the PI3K/AKT/mTOR Signaling Pathway in Endometrial Cancer'
    Oz, Hasan
    Canacankatan, Necmiye
    Antmen, Serife Efsun
    Aytan, Hakan
    Tuncel, Ferah
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2025,
  • [4] Molecular Alterations of PI3K/Akt/mTOR Pathway: A Therapeutic Target in Endometrial Cancer
    Pavlidou, Athanasia
    Vlahos, Nikos F.
    SCIENTIFIC WORLD JOURNAL, 2014,
  • [5] PI3K/AKT/mTOR pathway in angiogenesis
    Karar, Jayashree
    Maity, Amit
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2011, 4
  • [6] Investigational PI3K/AKT/mTOR inhibitors in development for endometrial cancer
    Barra, Fabio
    Evangelisti, Giulio
    Desideri, Lorenzo Ferro
    Di Domenico, Stefano
    Ferraioli, Domenico
    Vellone, Valerio Gaetano
    De Cian, Franco
    Ferrero, Simone
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2019, 28 (02) : 131 - 142
  • [7] PI3K/AKT/mTOR inhibitors for advanced or recurrent endometrial cancer
    Roncolato, Felicia
    Lindemann, Kristina
    Wilson, Melina L.
    Martyn, Julie
    Mileshkin, Linda
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2019, (10):
  • [8] CENPF facilitates endometrial cancer cell progression through PI3K/AKT/mTOR pathway
    Xiao, Huan
    Zhang, Zhi'an
    Wei, Chunqing
    Peng, Dan
    Guo, Yuge
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2023, 44 (01) : 106 - 114
  • [9] Vitexin suppresses the proliferation, angiogenesis and stemness of endometrial cancer through the PI3K/AKT pathway
    Liang, Cuixia
    Jiang, Yongjie
    Sun, Lizhu
    PHARMACEUTICAL BIOLOGY, 2023, 61 (01) : 581 - 589
  • [10] mTOR/PI3k/Akt SIGNALING PATHWAY IN TUMOR ANGIOGENESIS AND THERAPEUTIC TARGETING
    Mabeta, Peace
    Davis, Paul F.
    Pepper, Michael S.
    ANTICANCER RESEARCH, 2014, 34 (10) : 6042 - 6042